Douglas, Susan http://orcid.org/0000-0002-5239-4828
Bovendeerd, Bram http://orcid.org/0000-0003-0403-4008
van Sonsbeek, Maartje http://orcid.org/0000-0002-3932-1288
Manns, Mya
Milling, Xavier Patrick
Tyler, Ke’Sean
Bala, Nisha
Satterthwaite, Tim
Hovland, Runar Tengel
Amble, Ingunn
Atzil-Slonim, Dana
Barkham, Michael
de Jong, Kim
Kendrick, Tony
Nordberg, Samuel S.
Lutz, Wolfgang
Rubel, Julian A.
Skjulsvik, Tommy
Moltu, Christian http://orcid.org/0000-0003-3269-6383
Funding for this research was provided by:
Peabody College (Peabody College)
Førde Hospital Trust (Førde Hospital Trust)
Dimence Group (Dimence Group)
Article History
Accepted: 12 October 2023
First Online: 2 November 2023
Declarations
: Vanderbilt University and Susan Douglas receive compensation related to the Peabody Treatment Progress Battery; and Susan Douglas has a financial relationship with MIRAH, and both are Measurement-Based Care (MBC) tools. The author declares a potential conflict of interest. There is a management plan in place at Vanderbilt University to monitor that this potential conflict does not jeopardize the objectivity of Dr. Douglas’ research. Christian Moltu and Samuel S. Nordberg own equity in a Norwegian private company that markets and sells a clinical feedback technology based on the Norse Feedback methodology. The authors declare a potential conflict of interest. There is a management plan in place at Førde Hospital Trust to monitor that this potential conflict does not jeopardize the objectivity of Dr. Moltu’s research. Michael Barkham was the Principal Investigator in the development of the CORE Outcome Measure (1995-98) which has been used in feedback research. He is a CORE System Trustee but receives no financial benefit from the use of the measure.